Resultados de la búsqueda 81-90 of 9525 for B cell lymphomas

  1. Oncología (médica) - Ensayos clínicos

    Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia ( ...

  2. Oncología (médica) - Ensayos clínicos

    ... B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL). Jacksonville, Fla. The purpose of ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study evaluates CLR 131 in patients with select B-cell malignancies ... lymphoma (SLL), lymphoplasmacytic lymphoma (LPL), marginal zone lymphoma ...

  4. Oncología (médica) - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  5. Oncología (médica) - Ensayos clínicos

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary purpose of this study is to assess the safety and effectiveness of ALLO-501A to treat patients with relapsed/refractory large B cell lymphoma (LBCL) ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas ... B Cell Lymphoma (DLBCL), Hodgkin Lymphoma (HL) and Post-transplant ...

  8. Oncología (médica) - Ensayos clínicos

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Aggressive Malignancy PDX (Avatar) and ...

  9. Oncología (médica) - Ensayos clínicos

    1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

  10. Oncología (médica) - Ensayos clínicos

    ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...